Randomized Comparison of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent Implantation for De Novo Coronary Artery DisEase in Patients With DIABETES Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 11 Aug 2014
At a glance
- Drugs Zotarolimus (Primary) ; Sirolimus
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms ESSENCE-DM2
- 28 Jul 2014 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 12 Sep 2013 Primary endpoint 'Late-loss' has been met according to results published in the American Journal of Cardiology.
- 12 Sep 2013 Primary endpoint 'In-segment-restenosis' has been met according to results published in the American Journal of Cardiology.